NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-206-2024-0-US-01 MONOCLONAL ANTIBODIES TO NIPAH VIRUS AND THEIR USE US 63/729,879 Expired
NIAID E-137-2025-0-PC-01 ZIKA VIRUSES AND USES THEREOF PCT PCT PCT/US2024/058992 Pending
NLM E-111-2022-2-JP-01 ECHOCARDIOGRAPHIC ESTIMATION OF RIGHT ATRIAL PRESSURE USING A
LIGHTWEIGHT AND OPEN-WORLD ARTIFICIAL INTELLIGENCE SYSTEM 		JP National Stage 2024-572228 Abandoned
NLM E-111-2022-2-CA-01 ECHOCARDIOGRAPHIC ESTIMATION OF RIGHT ATRIAL PRESSURE USING A LIGHTWEIGHT AND OPEN-WORLD ARTIFICIAL INTELLIGENCE SYSTEM CA National Stage 3258628 Abandoned
NCI E-003-2025-0-US-01 LINKER FOR ANTIBODY-DRUG CONJUGATES AND ANTIBODY-DRUG CONJUGATES COMPRISING THE LINKER US 63/728,960 Expired
NCI E-121-2022-0-US-02 COMPOSITIONS, SYSTEMS, AND METHODS FOR DELIVERY OF THERAPEUTICS US National Stage 18/872,676 Pending
NLM E-111-2022-2-US-01 ECHOCARDIOGRAPHIC ESTIMATION OF RIGHT ATRIAL PRESSURE USING A LIGHTWEIGHT AND OPEN-WORLD ARTIFICIAL INTELLIGENCE SYSTEM US National Stage 18/872,402 Pending
NCATS E-006-2022-0-US-02 LATS INHIBITORS AND USES THEREOF US National Stage 18/872,732 Pending
NIDDK E-160-2022-0-US-02 COMPOSITIONS AND METHODS FOR PHARMACOLOGIC TREATMENT OF STROKE AND MYOCARDIAL ISCHEMIA REPERFUSION INJURY US National Stage 18/872,564 Pending
NIAID E-238-2024-0-US-01 Enhanced orthopoxvirus immunogenicity of recombinant vaccines US 63/729,008 Expired
NCI E-160-2018-0-US-07 RECOMBINANT GP120 PROTEIN WITH V1-LOOP DELETION US DIV 18/970,709 Pending
NIAID E-188-2015-0-US-01 POLYMER ADJUVANT US DIV 18/970,451 Pending
NLM E-111-2022-2-IL-01 ECHOCARDIOGRAPHIC ESTIMATION OF RIGHT ATRIAL PRESSURE USING A LIGHTWEIGHT AND OPEN-WORLD ARTIFICIAL INTELLIGENCE SYSTEM IL National Stage 317482 Abandoned
NICHD E-115-2022-0-KR-01 PROGESTIN / TESTOSTERONE TRANSDERMAL GEL KR National Stage 10-2024-7040471 Pending
NIDDK E-160-2022-0-EP-01 COMPOSITIONS AND METHODS FOR PHARMACOLOGIC TREATMENT OF STROKE AND MYOCARDIAL ISCHEMIA REPERFUSION INJURY EP National Stage 23820392.1 Pending
NCATS E-072-2022-1-HK-01 MULTI-CYCLC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF HK EP 62024100420.4 Pending
NIAID E-197-2023-1-CA-01 ANTI-SARS-CoV-2 ANTIGEN BINDING POLYPEPTIDES, POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF [COM5] CA National Stage 3258438 Pending
NCATS E-156-2022-0-US-02 COMPOUNDS FOR INHIBITING GRAM-POSITIVE BACTERIA US National Stage 18/871,571 Pending
NIDDK E-160-2022-0-CA-01 COMPOSITIONS AND METHODS FOR PHARMACOLOGIC TREATMENT OF STROKE AND MYOCARDIAL ISCHEMIA REPERFUSION INJURY CA National Stage 3258204 Pending
NICHD E-115-2022-0-EP-01 PROGESTIN / TESTOSTERONE TRANSDERMAL GEL EP EP 23729548.0 Pending
NEI E-156-2023-0-PC-01 MODIFIED PIGMENT EPITHELIUM-DERIVED FACTOR PEPTIDES AND METHODS OF USE PCT PCT PCT/US2024/057784 Pending
NIAID E-093-2022-0-US-02 COMPOSITIONS AND METHODS FOR DETECTING LYMPHATIC FILARIASIS US National Stage 18/869,777 Pending
NHLBI E-036-2022-0-CN-01 SABRE CATALYSTS CONTAINING FLUORINATED CARBON CHAINS FOR DELIVERY OF METAL-FREE MRI CONTRAST AGENTS CN National Stage 202380043074.0 Abandoned
NCI E-237-2017-1-EP-01 METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION EP DIV 24215129.8 Pending
NIAID E-234-2016-1-US-06 PREFUSION CORONAVIRUS SPIKE PROTEINS AND THEIR USE US CON 18/959,104 Abandoned
NCI E-186-2022-0-IL-01 PREDICTING PATIENT RESPONSE TO CANCER THERAPY VIA HISTOPATHOLOGY IMAGES IL National Stage 317206 Pending
NIAID E-026-2024-0-PC-01 BROADLY NEUTRALIZING INFLUENZA HEMAGGLUTININ STEM-DIRECTED ANTIBODIES PCT PCT PCT/US2024/057131 Pending
NIDA E-046-2024-2-PCT-01 DEVELOPMENT OF BROAD-SPECTRUM ANTI-OPIOID VACCINES PCT PCT COMB PCT/US2024/057069 Pending
NIAID E-026-2026-0-EP-01 An intranasal nozzle EP EP 24306951.5 Pending
NCI E-186-2022-0-US-02 PREDICTING PATIENT RESPONSE TO CANCER THERAPY VIA HISTOPATHOLOGY IMAGES US National Stage 18/868,028 Pending
NIAID E-028-2025-0-US-01 ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS THAT BIND TO MONKEYPOX VIRUSPROTEIN A35 AND VACCINIA VIRUS PROTEIN A33 AND METHODS OF USE US 63/723,296 Expired
NIAID E-137-2018-2-JP-02 Peptide-based Vaccines, Methods Of Manufacturing, And Uses Thereof For Inducing An Immune Response JP DIV 2024-202553 Issued
NCI E-112-2022-0-EP-01 GENETICALLY ENGINEERED CELLS, THEIR USES, AND METHODS OF MAKING SAME EP National Stage 23725347.1 Pending
NICHD E-115-2022-0-AU-01 PROGESTIN / TESTOSTERONE TRANSDERMAL GEL AU National Stage 2023268393 Pending
NCI E-176-2014-0-AU-02 Anti-Human Papillomavirus 16 E7 T Cell Receptors AU DIV 2024266702 Abandoned
NICHD E-115-2022-0-NZ-01 PROGESTIN / TESTOSTERONE TRANSDERMAL GEL NZ National Stage 816334 Pending
NCI E-126-2022-0-IN-01 VACCINE FOR HUMAN T-LYMPHOTROPIC VIRUS-1 IN National Stage 202417088469 Pending
NHLBI E-052-2022-0-CN-01 INFUSION DEVICE FOR THE PREPARATION AND DELIVERY OF MRI PROBES CN National Stage 202380040403.6 Abandoned
NCI E-126-2022-0-AU-01 VACCINE FOR HUMAN T-LYMPHOTROPIC VIRUS-1 AU National Stage 2023268543 Pending
NCI E-172-2022-0-US-02 SMALL CELL LUNG CANCER SUBTYPING USING PLASMA CELL-FREE NUCLEOSOMES US National Stage 18/865,855 Pending
NCI E-233-2014-0-CN-01 METHODS OF ISOLATING T CELL RECEPTORS HAVING ANTIGENIC SPECIFICITY FOR A CANCER-SPECIFIC MUTATION CN DIV 202411616177.4 Pending
NICHD E-115-2022-0-ZA-01 PROGESTIN / TESTOSTERONE TRANSDERMAL GEL ZA National Stage 2024/08634 Pending
NCI E-040-2012-0-US-02 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen US CON 18/944,297 Pending
NICHD E-115-2022-0-US-02 PROGESTIN / TESTOSTERONE TRANSDERMAL GEL US CON 18/941,896 12502395 Issued PDF
NCI E-126-2022-0-US-02 VACCINE FOR HUMAN T-LYMPHOTROPIC VIRUS-1 US National Stage 18/864,213 Pending
NICHD E-115-2022-0-CN-01 PROGESTIN / TESTOSTERONE TRANSDERMAL GEL CN National Stage 202380039231.0 Pending
NIAID E-251-2016-0-US-06 METHODS OF DIAGNOSING AND TREATING CD55 DEFICIENCY, HYPERACTIVATION OF COMPLEMENT, ANGIOPATHIC THROMBOSIS AND PROTEIN LOSING ENTEROPATHY (CHAPLE), A NEWLY IDENTIFIED ORPHAN DISEASE US CON 18/940,756 Pending
NIA E-017-2025-0-US-01 DIAGNOSTIC BIOMARKER FOR AMYOTROPHIC LATERAL SCLEROSIS BASED ON PLASMA PROTEIN MEASUREMENTS US 63/717,807 Expired
NICHD E-115-2022-0-MX-01 PROGESTIN / TESTOSTERONE TRANSDERMAL GEL MX National Stage MX/a/2024/013741 Pending
NHLBI E-061-2022-0-US-02 SYSTEMS AND METHOD FOR SYNCHRONOUS CIRCUMFERENTIAL INTRAMYOCARDIAL RESYNCHRONIZATION AND PACING US National Stage 18/863,596 Pending